Subependymal giant cell astrocytoma: Diagnosis, screening, and treatment. Recommendations from the international tuberous sclerosis complex consensus conference 2012

Pediatric Neurology

Volumn 49, Issue 6, 2013, Pages 439-444

  Roth, Jonathan ^a   Roach, E Steve ^b   Bartels, Ute ^c   Jóźwiak, Sergiusz ^d   Koenig, Mary Kay ^e   Weiner, Howard L ^f   Franz, David N ^g   Wang, Henry Z ^h  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

mTOR inhibitor; subependymal giant cell astrocytoma; surgery; tuberous sclerosis complex

Indexed keywords

EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;

ARTICLE; BRAIN INTERVENTRICULAR FORAMEN; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURGERY; COMORBIDITY; HUMAN; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; TREATMENT PLANNING;

MTOR INHIBITOR; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; SURGERY; TUBEROUS SCLEROSIS COMPLEX;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CONGRESSES AS TOPIC; FEMALE; GUIDELINES AS TOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; SIROLIMUS; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 84888288213     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2013.08.017     Document Type: Article

References (40)

1. J. Borkowska, R.A. Schwartz, K. Kotulska, and S. Jozwiak Tuberous sclerosis complex: tumors and tumorigenesis Int J Dermatol 50 2011 13 20
2. P. Curatolo, R. Bombardieri, and S. Jozwiak Tuberous sclerosis Lancet 372 2008 657 668
3. P.B. Crino, K.L. Nathanson, and E.P. Henske The tuberous sclerosis complex New Engl J Med 355 2006 1345 1356
4. J.P. Osborne, A. Fryer, and D. Webb Epidemiology of tuberous sclerosis Ann NY Acad Sci 615 1991 125 127
5. R.A. Schwartz, G. Fernández, K. Kotulska, and S. Jóźwiak Tuberous sclerosis complex: advances in diagnosis, genetics, and management J Am Acad Dermatol 57 2007 189 202
6. M.E. Adriaensen, C.M. Schaefer-Prokop, T. Stijnen, D.A. Duyndam, B.A. Zonnenberg, and M. Prokop Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature Eur J Neurol 16 2009 691 696
7. H. Northrup, D. Krueger for the 2012 International Tuberous Sclerosis Complex Consensus Group Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference Pediatr Neurol 49 2013 243 254
8. D. Krueger, H. Northrup for the 2012 International Tuberous Sclerosis Complex Consensus Group Tuberous sclerosis complex surveillance and management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference Pediatr Neurol 49 2013 255 265
9. J. Vaughn, M. Hagiwara, and J. Katz MRI characterization and longitudinal study of focal cerebellar lesions in a young tuberous sclerosis cohort AJNR Am J Neuroradiol 34 2013 655 659
10. G. Ertan, S. Arulrajah, A. Tekes, L. Jordan, and T.A. Huisman Cerebellar abnormality in children and young adults with tuberous sclerosis complex: MR and diffusion weighted imaging findings J Neuroradiol 37 2010 231 238
11. J.S. Katz, S.S. Milla, G.C. Wiggins, O. Devinsky, H.L. Weiner, and J. Roth Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus J Neurosurg Pediatr 9 2012 406 413
12. R.J. Bollo, J.L. Berliner, and I. Fischer Extraventricular subependymal giant cell tumor in a child with tuberous sclerosis complex J Neurosurg Pediatr 4 2009 85 90
13. D.N. Louis, H. Ohgaki, and O.D. Wiestler The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2007 97 109
14. E.S. Roach, M.R. Gomez, and H. Northrup Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria J Child Neurol 13 1998 624 628
15. H. Matsumura, H. Takimoto, N. Shimada, M. Hirata, T. Ohnishi, and T. Hayakawa Glioblastoma following radiotherapy in a patient with tuberous sclerosis Neurol Medico-chirurgica 38 1998 287 291
16. P. Sun, M. Kohrman, J. Liu, A. Guo, J. Rogerio, and D. Krueger Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis Curr Med Res Opinion 28 2012 657 663
17. T. Jiang, G. Jia, Z. Ma, S. Luo, and Y. Zhang The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis Childs Nervous Syst 27 2011 55 62
18. S. Goh, W. Butler, and E.A. Thiele Subependymal giant cell tumors in tuberous sclerosis complex Neurology 63 2004 1457 1461
19. M.A. Ekici, S. Kumandas, and H. Per Surgical timing of the subependymal giant cell astrocytoma (SEGA) with the patients of tuberous sclerosis complex Turkish Neurosurg 21 2011 315 324
20. S. de Ribaupierre, G. Dorfmuller, and C. Bulteau Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate? Neurosurgery 60 2007 83 89 discussion 89-90
21. V. Cuccia, G. Zuccaro, F. Sosa, J. Monges, F. Lubienieky, and A.L. Taratuto Subependymal giant cell astrocytoma in children with tuberous sclerosis Childs Nervous Syst 19 2003 232 243
22. S. Amin, M. Carter, and R.J. Edwards The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex Eur J Paediatr Neurol 17 2013 36 44
23. D.A. Krueger, M.M. Care, and K. Holland Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis New Engl J Med 363 2010 1801 1811
24. D.A. Krueger, M.M. Care, K. Agricola, C. Tudor, M. Mays, and D.N. Franz Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma Neurology 80 2013 574 580
25. D.N. Franz, E. Belousova, and S. Sparagana Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial Lancet 381 2013 125 132
26. K. Kotulska, D. Chmielewski, and J. Borkowska Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex Eur J Paediatr Neurol 17 2013 479 485
27. D.N. Franz, K.D. Agricola, C.A. Tudor, and D.A. Krueger Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex J Child Neurol 28 2013 602 607
28. D.N. Franz, J. Leonard, and C. Tudor Rapamycin causes regression of astrocytomas in tuberous sclerosis complex Ann Neurol 59 2006 490 498
29. C.J. Campen, and B.E. Porter Subependymal giant cell astrocytoma (SEGA) treatment update Curr Treatment Options Neurol 13 2011 380 385
30. S. Jozwiak, R. Nabbout, and P. Curatolo Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations Eur J Paediatr Neurol 17 2013 348 352
31. K. Agricola, C. Tudor, D. Krueger, and D. Neal Nursing implications for the lifelong management of tuberous sclerosis complex J Neurosci Nurs 45 2013 223 239
32. U. Isik, A. Dincer, A. Sav, and M.M. Ozek Basal ganglia location of subependymal giant cell astrocytomas in two infants Pediatr Neurol 42 2010 157 159
33. M. Perek-Polnik, S. Jóźwiak, E. Jurkiewicz, D. Perek, and K. Kotulska Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex Eur J Paediatr Neurol 16 2012 83 85
34. F.X. McCormack, Y. Inoue, and J. Moss Efficacy and safety of sirolimus in lymphangioleiomyomatosis New Engl J Med 364 2011 1595 1606
35. J.J. Bissler, J.C. Kingswood, and E. Radzikowska Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial Lancet 381 2013 817 824
36. J.J. Bissler, F.X. McCormack, and L.R. Young Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis New Engl J Med 358 2008 140 151
37. A.M. Cappellano, A.A. Senerchia, and F. Adolfo Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex Childs Nervous Syst 2013 [e-pub ahead of print]
38. D.A. Krueger, A.A. Wilfong, and K. Holland-Bouley Everolimus treatment of refractory epilepsy in tuberous sclerosis complex Ann Neurol 2013 [e-pub ahead of print]
39. G. Wiegand, T.W. May, P. Ostertag, R. Boor, U. Stephani, and D.N. Franz Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option? Eur J Paediatr Neurol 2013 [e-pub ahead of print]
40. K. Kotulska, J. Borkowska, and S. Jozwiak Possible prevention of tuberous sclerosis complex lesions Pediatrics 132 2013 e239 e242